Oncotarget

Research Papers: Immunology:

Synergistic antibiotic effect of looped antimicrobial peptide CLP-19 with bactericidal and bacteriostatic agents

Di Li, Ya Yang, Zhiqiang Tian, Jun Lv, Fengjun Sun, Qian Wang, Yao Liu and Peiyuan Xia _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:55958-55966. https://doi.org/10.18632/oncotarget.18124

Metrics: PDF 2046 views  |   HTML 3318 views  |   ?  


Abstract

Di Li1,2,*, Ya Yang1,*, Zhiqiang Tian3, Jun Lv1, Fengjun Sun1, Qian Wang1, Yao Liu1 and Peiyuan Xia1

1 Department of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, China

2 Department of Pharmacy, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

3 Department of Immunology, Third Military Medical University, Chongqing, China

* These authors have contributed equally to this work

Correspondence to:

Peiyuan Xia, email:

Yao Liu, email:

Keywords: antimicrobial peptides, CLP-19, synergistic effect, hydroxyl radicals, LPS, Immunology and Microbiology Section, Immune response, Immunity

Received: January 17, 2017 Accepted:April 15, 2017 Published: May 23, 2017

Abstract

The treatment of drug-resistant infections is complicated and the alarming rise in infectious diseases poses a unique challenge for development of effective therapeutic strategies. Antibiotic-induced liberation of the bacterial endotoxin lipopolysaccharide (LPS) may have immediate adverse effects promoting septic shock in patients. In the present study, we first confirmed our previous finding that looped antimicrobial peptide CLP-19 exerts non-specific direct antibacterial activity with no toxic to mammalian cells and second revealed that CLP-19 has synergistic effect to enhance the antibacterial activities of other conventional bactericidal (ampicillin and ceftazidime) and bacteriostatic (erythromycin and levofloxacin) agents. Third, the underlying mechanism of antibiotic effect was likely associated with stimulation of hydroxyl radical generation. Lastly, CLP-19 was shown to effectively reduce the antibiotic-induced liberation of LPS, through direct neutralization of the LPS. Thus, CLP-19 is a potential therapeutic agent for combinatorial antibiotic therapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18124